- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review
Authors
Keywords
-
Journal
Biomedicines
Volume 10, Issue 2, Pages 261
Publisher
MDPI AG
Online
2022-01-26
DOI
10.3390/biomedicines10020261
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Co-delivery of Salinomycin and Curcumin for Cancer Stem Cell Treatment by Inhibition of Cell Proliferation, Cell Cycle Arrest, and Epithelial–Mesenchymal Transition
- (2021) Yongmei Zhao et al. Frontiers in Chemistry
- Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling
- (2021) Lauren Brady et al. Nature Communications
- Nanopore Sequencing Reveals Global Transcriptome Signatures of Mitochondrial and Ribosomal Gene Expressions in Various Human Cancer Stem-like Cell Populations
- (2021) Kaya E. Witte et al. Cancers
- CD44v6-targeted CAR T-cells specifically eliminate CD44 isoform 6 expressing head/neck squamous cell carcinoma cells
- (2021) Corinna Haist et al. ORAL ONCOLOGY
- Multiregional Sequencing of IDH-WT Glioblastoma Reveals High Genetic Heterogeneity and a Dynamic Evolutionary History
- (2021) Sara Franceschi et al. Cancers
- Novel Primary Human Cancer Stem-Like Cell Populations from Non-Small Cell Lung Cancer: Inhibition of Cell Survival by Targeting NF-κB and MYC Signaling
- (2021) Beatrice A. Windmöller et al. Cells
- Regulation of antitumor immunity by inflammation-induced epigenetic alterations
- (2021) Michael Karin et al. Cellular & Molecular Immunology
- Analysis of Several Pathways for Efficient Killing of Prostate Cancer Stem Cells: A Central Role of NF-κB RELA
- (2021) Kaya E. Witte et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Trends in kinase drug discovery: targets, indications and inhibitor design
- (2021) Misty M. Attwood et al. NATURE REVIEWS DRUG DISCOVERY
- The Transcription Factor NF-κB in Stem Cells and Development
- (2021) Christian Kaltschmidt et al. Cells
- Ferroptosis: Cancer Stem Cells Rely on Iron until “to Die for” It
- (2021) Emma Cosialls et al. Cells
- Systemic dysfunction and plasticity of the immune macroenvironment in cancer models
- (2020) Breanna M. Allen et al. NATURE MEDICINE
- Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
- (2020) Rowa Y. Alhabbab Frontiers in Genetics
- Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
- (2020) Lia Walcher et al. Frontiers in Immunology
- Isolation and Characterization of Two Novel Colorectal Cancer Cell Lines, Containing a Subpopulation with Potential Stem-Like Properties: Treatment Options by MYC/NMYC Inhibition
- (2020) Jan Schulte am Esch et al. Cancers
- Regulation of PD-L1 Expression by NF-κB in Cancer
- (2020) Fabrizio Antonangeli et al. Frontiers in Immunology
- Endogenous production of IL-1B by breast cancer cells drives metastasis and colonisation of the bone microenvironment.
- (2019) Claudia Tulotta et al. CLINICAL CANCER RESEARCH
- IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes
- (2019) Piero Ruscitti et al. MEDICINE
- A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer
- (2019) F. Coussy et al. INTERNATIONAL JOURNAL OF CANCER
- A Role for NF-κB in Organ Specific Cancer and Cancer Stem Cells
- (2019) Christian Kaltschmidt et al. Cancers
- Tumor angiogenesis: causes, consequences, challenges and opportunities
- (2019) Roberta Lugano et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Salinomycin reduces growth, proliferation and metastasis of cisplatin resistant breast cancer cells via NF-kB deregulation
- (2019) Mrityunjay Tyagi et al. TOXICOLOGY IN VITRO
- T regulatory cells mediate immunosuppresion by adenosine in peripheral blood, sentinel lymph node and TILs from melanoma patients
- (2018) P. Di Gennaro et al. CANCER LETTERS
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Antitumor activity of EGFR-specific CAR T cells against non-small-cell lung cancer cells in vitro and in mice
- (2018) He Li et al. Cell Death & Disease
- Programming CAR-T cells to kill cancer
- (2018) Louai Labanieh et al. Nature Biomedical Engineering
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Intra-tumor heterogeneity from a cancer stem cell perspective
- (2017) Pramudita R. Prasetyanti et al. Molecular Cancer
- Salinomycin kills cancer stem cells by sequestering iron in lysosomes
- (2017) Trang Thi Mai et al. Nature Chemistry
- Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PDL1 blockade
- (2017) Jie Bai et al. Oncotarget
- Expression of PD-1/PD-L1 and PD-L2 in peripheral T-cells from non-small cell lung cancer patients
- (2017) Oscar Arrieta et al. Oncotarget
- Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models
- (2017) Lucia Martinez-Cruzado et al. NEOPLASIA
- Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
- (2015) Zhenling Deng et al. BMC IMMUNOLOGY
- A Cytoplasmic NF-κB Interacting Long Noncoding RNA Blocks IκB Phosphorylation and Suppresses Breast Cancer Metastasis
- (2015) Bodu Liu et al. CANCER CELL
- Global Cancer Incidence and Mortality Rates and Trends--An Update
- (2015) L. A. Torre et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Nestin as a marker of cancer stem cells
- (2015) Jakub Neradil et al. CANCER SCIENCE
- Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
- (2015) Michael D. Brooks et al. Cell Stem Cell
- Autophagy, Metabolism, and Cancer
- (2015) E. White et al. CLINICAL CANCER RESEARCH
- iTreg induced from CD39+ naive T cells demonstrate enhanced proliferate and suppressive ability
- (2015) Yunjie Lu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
- (2015) Xin Ye et al. NATURE
- NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer
- (2015) Collin M. Blakely et al. Cell Reports
- Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57
- (2015) Xuekai Zhu et al. Oncotarget
- Evolution of the Cancer Stem Cell Model
- (2014) Antonija Kreso et al. Cell Stem Cell
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Tumor Macroenvironment and Metabolism
- (2014) Wael Al-Zhoughbi et al. SEMINARS IN ONCOLOGY
- NF- B, an Active Player in Human Cancers
- (2014) Y. Xia et al. Cancer Immunology Research
- Salinomycin inhibits Akt/NF-κB and induces apoptosis in cisplatin resistant ovarian cancer cells
- (2013) Bidur Parajuli et al. Cancer Epidemiology
- The complexity of NF-κB signaling in inflammation and cancer
- (2013) Bastian Hoesel et al. Molecular Cancer
- Acute myeloid leukemia stem cells and CD33-targeted immunotherapy
- (2012) R. B. Walter et al. BLOOD
- Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress
- (2012) K Ketola et al. BRITISH JOURNAL OF CANCER
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges
- (2012) Philipp Grosse-Gehling et al. JOURNAL OF PATHOLOGY
- The developing cancer stem-cell model: clinical challenges and opportunities
- (2012) Louis Vermeulen et al. LANCET ONCOLOGY
- Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast
- (2011) Christina Scheel et al. CELL
- Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
- (2011) C. L. Chaffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of known drugs that act as inhibitors of NF-κB signaling and their mechanism of action
- (2010) Susanne C. Miller et al. BIOCHEMICAL PHARMACOLOGY
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Persistent Malignant Stem Cells in del(5q) Myelodysplasia in Remission
- (2010) Ramin Tehranchi et al. NEW ENGLAND JOURNAL OF MEDICINE
- NFKBIADeletion in Glioblastomas
- (2010) Markus Bredel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients’ outcome
- (2009) Ting Li et al. LABORATORY INVESTIGATION
- Autoregulatory feedback loops terminating the NF-κB response
- (2009) Florian Renner et al. TRENDS IN BIOCHEMICAL SCIENCES
- NF- B in the Nervous System
- (2009) B. Kaltschmidt et al. Cold Spring Harbor Perspectives in Biology
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- Is NF-κB a good target for cancer therapy? Hopes and pitfalls
- (2008) Véronique Baud et al. NATURE REVIEWS DRUG DISCOVERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started